Valuation: Smith & Nephew Plc

Capitalization 15.17B 13.05B 11.84B 11.35B 20.73B 1,399B 21.48B 139B 55.69B 667B 56.95B 55.73B 2,382B P/E ratio 2025
23.3x
P/E ratio 2026 * 20.3x
Enterprise value 17.85B 15.35B 13.93B 13.36B 24.4B 1,646B 25.28B 164B 65.52B 785B 67.01B 65.57B 2,803B EV / Sales 2025
2.3x
EV / Sales 2026 * 2.71x
Free-Float
99.43%
Yield 2025 *
2.33%
Yield 2026 * 2.2%
1 day-1.68%
1 week-2.88%
Current month-4.19%
1 month+1.58%
3 months+3.87%
6 months-7.20%
Current year+6.10%
1 week 1,289.5
Extreme 1289.5
1,396.5
1 month 1,245.5
Extreme 1245.5
1,396.5
Current year 1,170.5
Extreme 1170.5
1,396.5
1 year 937.8
Extreme 937.8
1,441.5
3 years 887
Extreme 887
1,441.5
5 years 887
Extreme 887
1,601.5
10 years 887
Extreme 887
2,023
Manager TitleAgeSince
Chief Executive Officer - 01/04/2022
Director of Finance/CFO 58 01/04/2024
Chief Tech/Sci/R&D Officer 59 01/08/2016
Director TitleAgeSince
Director/Board Member 68 18/09/2017
Director/Board Member 67 01/10/2017
Director/Board Member 62 01/11/2020
Change 5d. change 1-year change 3-years change Capi.($)
-1.68%-2.88%+12.40%+8.73% 15.17B
-0.70%-0.56%-2.06%+40.64% 146B
-2.02%-4.57%+2.82%+129.05% 6.7B
+0.83%-4.50%-18.02%-66.54% 6.08B
-3.55%-5.81%+33.80%+28.87% 2.67B
-3.56%-2.31%-17.40%-24.78% 2B
-1.71%+5.82%+15.98%-16.39% 1.88B
-2.25%+8.56%-64.48%-75.66% 1.84B
+1.98%+15.55%-29.57%-55.33% 1.48B
Average -1.39%+1.22%-7.39%-3.49% 20.44B
Weighted average by Cap. -0.71%-0.63%-1.52%+34.29%

Financials

2025 2026 *
Net sales 6.14B 5.28B 4.79B 4.59B 8.39B 566B 8.69B 56.25B 22.52B 270B 23.03B 22.54B 963B 6.51B 5.6B 5.08B 4.87B 8.9B 600B 9.22B 59.71B 23.91B 286B 24.45B 23.92B 1,023B
Net income 664M 571M 518M 497M 907M 61.21B 940M 6.09B 2.44B 29.19B 2.49B 2.44B 104B 748M 643M 584M 560M 1.02B 68.98B 1.06B 6.86B 2.75B 32.9B 2.81B 2.75B 117B
Net Debt 2.68B 2.3B 2.09B 2.01B 3.66B 247B 3.79B 24.57B 9.84B 118B 10.06B 9.84B 421B 2.5B 2.15B 1.95B 1.87B 3.41B 230B 3.54B 22.9B 9.17B 110B 9.38B 9.17B 392B
Logo Smith & Nephew Plc
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.7%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.4%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.8% of net sales.
Employees
17,000
Date Price Change Volume
05/03/26 1,316.00 p -1.50% 455,139
04/03/26 1,336.00 p -1.76% 3,753,590
03/03/26 1,360.00 p +3.58% 3,676,276
02/03/26 1,313.00 p -4.27% 5,328,677
27/02/26 1,371.50 p +1.37% 2,860,001
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
17.85USD
Average target price
19.03USD
Spread / Average Target
+6.61%

Quarterly revenue - Rate of surprise